Skip to menu Skip to content Skip to footer
Dr Christine Staatz
Dr

Christine Staatz

Email: 
Phone: 
+61 7 334 61974

Overview

Background

Christine graduated with a Bachelor of Pharmacy degree (honours class 1) from the University of Queensland in 1996.

She registered as a pharmacist in Australia in 1997 and in the United Kingdom in 2003 and has worked at the Redlands, Princess Alexandra and Wesley Hospitals in Brisbane and the Western Infirmary in Glasgow. In 2002 she was awarded a PhD from the University of Queensland, with a thesis focusing on improving usage of the immunosuppressant agent tacrolimus in solid organ transplant recipients.

In 2004 she was the recipient of a National Health and Medical Research Council (NHMRC) Neil Hamilton Fairley fellowship. This award enabled her to training overseas in the field of Pharmacometrics within the Department of Medicine and Therapeutics at the University of Glasgow (Scotland) and the Department of Pharmaceutical Biosciences at Uppsala University (Sweden).

On her return to Brisbane, Christine was the recipient of a Lions Medical Research Fellowship and was the chief investigator on a three year NHMRC Project Grant. She has also been a team member on an Amgen-Transplant Society of Australia and New Zealand Research Grant and a Cellcept Australia Research Grant. Over her research career Christine has attracted grants and awards totaling more than 2 million AUD from various funding agencies.

Research Interests

Christine has a wide range of interests in the fields of Quality Use of Medicine and Pharmacometrics. Her work to date has primarily been directed towards optimising usage of immunosuppressant drugs in solid organ transplant recipients and antibiotics in patients with life-threatening infections.

Christine has published over 75 peer reviewed papers and 90 conference abstracts on these topics. Her publications have been cited on more than 3200 occasions, with twelve cited more than 50 times.

Christine has successfully supervised to completion fourteen higher research degree students and enjoys helping students meet their career goals.

Christine’s current projects include:

  • Individualising immunosuppressant therapy in autoimmune disease to improve patient outcomes
  • Comparing the efficacy and safety of continuous versus intermittent administration of beta-lactams in critically ill patients
  • Examining the relationship between immunosuppression and non-melanoma skin cancer in renal transplant recipients
  • Improving individualisation of immunosuppressant therapy in adult kidney transplant recipients
  • Improving gentamycin dosing in paediatric oncology patients
  • Examining tobramycin monitoring in cystic fibrosis patients in Australia and the United Kingdom
  • Investigating the relationship between prednisolone exposure and drug-related toxicity in paediatric and adult kidney transplant recipients
  • Comparing different therapeutic drug monitoring methods for dosage adjustment of once daily intravenous tobramycin treatment in children with cystic fibrosis

Projects currently available for interested research higher degree students include:

  • Dose optimisation of busulfan in paediatric bone marrow transplant recipients
  • Investigating the relationship between immunosupressant exposure and drug-related toxicity in transplant recipients
  • Examining Bayesian forecasting methods to predict immunosuppressant exposure
  • Examining the international use of immunosuppressant and anti-rheumatic drugs
  • Examining the influence of plasma exchange on immunosuppressant drug exposure

Christine invites potential honours and post-graduate students to contact her via email to discuss research opportunities.

Teaching interests

Co-ordinates:

  • PHRM3052- Biological Fate of Drugs

Teaches in:

  • PHRM3052- Biological Fate of Drugs
  • PHRM3011- Quality Use of Medicines

Availability

Dr Christine Staatz is:
Available for supervision

Qualifications

  • Bachelor, The University of Queensland
  • Bachelor (Honours) of Pharmacy, The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Works

Search Professor Christine Staatz’s works on UQ eSpace

249 works between 1998 and 2025

241 - 249 of 249 works

2001

Journal Article

Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants

Staatz, Christine E., Taylor, Paul J., Lynch, Stephen V., Willis, Charlene, Charles, Bruce G. and Tett, Susan E. (2001). Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants. Transplantation, 72 (6), 1056-1061. doi: 10.1097/00007890-200109270-00013

Population pharmacokinetics of tacrolimus in children who receive cut-down or full liver transplants

2001

Journal Article

Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation

Staatz, C, Taylor, P and Tett, S (2001). Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation. Nephrology Dialysis Transplantation, 16 (9), 1905-1909. doi: 10.1093/ndt/16.9.1905

Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation

2000

Journal Article

Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?

Collins, D., Coombes, J., Staatz, C. E., Stowasser, D. and Stowasser, M. (2000). Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?. Australian Journal of Hospital Pharmacy, 30 (2), 47-52.

Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?

2000

Journal Article

Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?

Stowasser, Danielle A., Staatz, Christine E., Stowasser, Michael, Coombes, Judith A. and Collins, David M. (2000). Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?. Australian Journal of Hospital Pharmacy, 30 (2), 47-53. doi: 10.1002/jppr200030247

Identifying Drug-Related Readmissions: Is There a Better Way of Assessing the Contribution of Adverse Medication Events?

2000

Conference Publication

Nonmen

Staatz, C. and Tett, S. E. (2000). Nonmen. Joint Meeting of ASCEPT and the British Pharmacological Society, Monash University, Melbourne, 25-28 April 2000. Australia: ASCEPT.

Nonmen

2000

Conference Publication

Bayesian forecasting to predict tacrolimus concentrations in paediatric liver transplant recipients

Willis, C., Staatz, C., Lynch, S. V. and Tett, S. E. (2000). Bayesian forecasting to predict tacrolimus concentrations in paediatric liver transplant recipients. Annual Scientific Meeting of ASCEPT 2000, Newcastle, NSW, Australia, 3-6 December, 2000. Lilydale, Vic.: ASCEPT.

Bayesian forecasting to predict tacrolimus concentrations in paediatric liver transplant recipients

1999

Conference Publication

Factors that influence the pharmacokinetics of Tacrolimus in paediatric liver transplant recipients

Staatz, C., Lynch, S. V., Taylor, P. J., Willis, C. and Tett, S. E (1999). Factors that influence the pharmacokinetics of Tacrolimus in paediatric liver transplant recipients. ASCEPT Conference, Sydney, N.S.W., December, 1999. Sydney: ASCEPT.

Factors that influence the pharmacokinetics of Tacrolimus in paediatric liver transplant recipients

1999

Conference Publication

Population pharmacokinetics of tacrolimus in Australian paediatric and adult liver transplant recipients

Staatz, C., Taylor, P. J., Lynch, S. V., Charles, B. G. and Tett, S.E (1999). Population pharmacokinetics of tacrolimus in Australian paediatric and adult liver transplant recipients. 6th International Congress of IATDMCT, Cairns, Qld, 13-17 September, 1999. New York: Lippincott-Raven.

Population pharmacokinetics of tacrolimus in Australian paediatric and adult liver transplant recipients

1998

Journal Article

Ester prodrugs of a potent analgesic, morphine-6-sulfate: syntheses, spectroscopic and physicochemical properties

PreechagoonD, BreretonI, Staatz, C and PrankerdR (1998). Ester prodrugs of a potent analgesic, morphine-6-sulfate: syntheses, spectroscopic and physicochemical properties. International Journal of Pharmaceutics, 163 (1-2), 177-190. doi: 10.1016/S0378-5173(97)00381-5

Ester prodrugs of a potent analgesic, morphine-6-sulfate: syntheses, spectroscopic and physicochemical properties

Funding

Current funding

  • 2024 - 2026
    Exploring the impact of BUsulfan METabolites on busulfan clearance, exposure and patient outcomes following Haematopoietic Stem Cell Transplantation (BU-MET-HSCT). (QHCRF administered by CHQ HHS)
    Children's Health Queensland Hospital and Health Service
    Open grant

Past funding

  • 2019 - 2020
    Evaluating immunosuppressant medicines in elderly renal transplant recipients
    Metro South Hospital and Health Service
    Open grant
  • 2018 - 2019
    Bu4DayPK - Analysis of once daily IV Busulfan in paediatric HSCT patients
    Children's Health Queensland Hospital and Health Service
    Open grant
  • 2018 - 2019
    Innovative blood sampling to reduce the burden of long-term treatment for kidney transplant recipients
    Metro North Hospital and Health Service
    Open grant
  • 2014
    Designing optimal dosing regimens for immunosuppressant medications
    Queensland Pharmacy Research Trust
    Open grant
  • 2010 - 2011
    Examining the relationship between immunosuppression and BK virus infection in adult kidney transplant recipients
    UQ New Staff Research Start-Up Fund
    Open grant
  • 2010
    Analytical instrumentation enabling rapid compound separation and chemical structure analysis via mass fingerprinting
    UQ Major Equipment and Infrastructure
    Open grant
  • 2008 - 2011
    Lions Medical Research Foundation Fellowship - Tailoring doses of the newer immunosuppressant drugs to improve outcomes after transplant
    Lions Medical Research Foundation
    Open grant
  • 2008 - 2011
    Improved patient outcomes through dosage individualisation of the newer immunosuppressant drugs
    NHMRC Project Grant
    Open grant
  • 2008
    UQ Travel Awards Category 2 - Christine Staatz
    UQ Travel Grants Scheme
    Open grant
  • 2004 - 2008
    NEIL HAMILTON FAIRLEY FELLOWSHIP: Population Pharmacokinetic And Pharmacodynamic Modelling Of The Newer Immunosuppressant Drugs
    NHMRC Training (Postdoctoral) Fellowship
    Open grant

Supervision

Availability

Dr Christine Staatz is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

Completed supervision

Media

Enquiries

For media enquiries about Dr Christine Staatz's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au